Centre for Policy on Ageing
 

 

Dementia care costs and outcomes
 — a systematic review
Author(s)Martin Knapp, Valentina Iemmi, Renee Romeo
Journal titleInternational Journal of Geriatric Psychiatry, vol 28, no 6, June 2013
PublisherWiley, June 2013
Pagespp 551-561
Sourcewww.orangejournal.org
KeywordsDementia ; Therapeutics ; Drugs ; Costs [care] ; Cost effectiveness ; Literature reviews.
AnnotationThe present study aimed to review evidence on the cost-effectiveness of prevention, care and treatment strategies in relation to dementia. A systematic review of available literature on economic evaluations of dementia care was carried out in which 56 literature reviews and 29 single studies were identified. There was found to be more cost-effectiveness evidence on pharmacological therapies than other interventions. Acetylcholinesterase inhibitors for mild-to-moderate disease and memantine for moderate-to-severe disease were found to be cost-effective. Regarding non-pharmacological treatments, cognitive stimulation therapy, tailored activity programme and occupational therapy were found to be more cost-effective than usual care. There was some evidence to suggest that respite care in day settings and psychosocial interventions for carers could be cost-effective. Coordinated care management and personal budgets held by carers have also demonstrated cost-effectiveness in some studies. In all, five barriers to achieving better value for money in dementia care were identified: the scarcity and low methodological quality of available studies, the difficulty of generalising from available evidence, the narrowness of cost measures, a reluctance to implement evidence and the poor coordination of health and social care provision and financing. (JL).
Accession NumberCPA-130531205 A
ClassmarkEA: LL: LLD: QDC: WEC: 64A

Data © Centre for Policy on Ageing

...from the Ageinfo database published by Centre for Policy on Ageing.
 

CPA home >> Ageinfo Database >> Queries to: webmaster@cpa.org.uk